C21 · Pharmaceuticals · European Union
New medicines recommended for approval (monthly)
European Union: 12 in July 2026.
- 12 Latest · European Union · July 2026
- Monthly Release cadence
- 1 Record · 1 region · 2026
Verified 15 Sep 2026 · 1 publisher · Next period August 2026
The figure
One published observation so far. A chart follows as soon as a second period is published.
New medicines recommended for approval (monthly)
European Union, July 2026
Every record
1 record · 1 region · 2026. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: EMA. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (EMA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Number of new medicines recommended for marketing authorisation by the medicines regulatory committee at its monthly meeting.
- Measure
- One slice of Marketing authorisation recommendations ( form: count ) . Total number of medicines receiving positive regulatory recommendations for marketing authorization. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026 | EMA | — | 1 |
Frequently asked questions
What is the latest new medicines recommended for approval (monthly)?
European Union: 12 in July 2026.
Where does this data come from?
From 1 document published by EMA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Monthly. The newest published period is July 2026; the next release should cover August 2026. A new figure appears here once the publisher releases it and it passes verification.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). New medicines recommended for approval (monthly) [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/new-medicines-recommended-for-approval-monthly
"New medicines recommended for approval (monthly)." StatOrigin, 2026, https://statorigin.org/indicators/new-medicines-recommended-for-approval-monthly. Accessed 28 Oct. 2026.
StatOrigin. "New medicines recommended for approval (monthly)." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/new-medicines-recommended-for-approval-monthly.
@misc{statorigin_new_medicines_recommended_for_approval_monthly_2026, title = {New medicines recommended for approval (monthly)}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/new-medicines-recommended-for-approval-monthly}, note = {Data set. Accessed 2026-10-28} }